1. Home
  2. ELA vs ABEO Comparison

ELA vs ABEO Comparison

Compare ELA & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envela Corporation

ELA

Envela Corporation

HOLD

Current Price

$12.99

Market Cap

334.4M

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.02

Market Cap

280.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELA
ABEO
Founded
1965
1974
Country
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
334.4M
280.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ELA
ABEO
Price
$12.99
$5.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$11.50
$18.20
AVG Volume (30 Days)
80.4K
1.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$19.13
N/A
Revenue Next Year
$2.46
$1,589.77
P/E Ratio
$33.91
$3.92
Revenue Growth
N/A
N/A
52 Week Low
$5.10
$3.93
52 Week High
$15.11
$7.54

Technical Indicators

Market Signals
Indicator
ELA
ABEO
Relative Strength Index (RSI) 49.64 46.55
Support Level $12.65 $4.94
Resistance Level $13.44 $5.26
Average True Range (ATR) 0.68 0.23
MACD -0.10 -0.01
Stochastic Oscillator 23.85 37.01

Price Performance

Historical Comparison
ELA
ABEO

About ELA Envela Corporation

Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: